RA

Ravi Anantrao Shinde

Active Director Director DIN 09806859
DIN 09806859 First appointment Nov 2022 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Ravi Anantrao Shinde

Data last updated:

Ravi Anantrao Shinde is a Director at Myprime Healthcare Private Limited (since 2022). The company operates in Healthcare.

DIN 09806859
Primary Designation Director
Industry Healthcare
First Appointment 30 Nov 2022
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Myprime Healthcare Private Limited U85100MH2021PTC366493
Director30 Nov 20222021Active

Board colleagues of Ravi Anantrao Shinde

Directorship timeline

Open interactive timeline →
Myprime Healthcare Private Limited
Premium access

Shareholding and investment profile for Ravi Anantrao Shinde

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravi Anantrao Shinde

Ravi Anantrao Shinde currently holds 1 directorship: Myprime Healthcare Private Limited (Director, since 30 Nov 2022).

Ravi Anantrao Shinde was first appointed on 30 Nov 2022 as Director at Myprime Healthcare Private Limited.

The current boards of Ravi Anantrao Shinde's companies include Aarti Appasaheb Parkhe (Myprime Healthcare Private Limited), Sachin Abasaheb Nikam (Myprime Healthcare Private Limited), Shridhar Namdeo Kachare (Myprime Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available